Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Mochida Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 1.76% and Operating profit at -6.29% over the last 5 years
2
Flat results in Mar 26
- INTEREST COVERAGE RATIO(Q) Lowest at 8,119.05
- CASH AND EQV(HY) Lowest at JPY 72,554 MM
- DEBT-EQUITY RATIO (HY) Highest at -14.77 %
3
Underperformed the market in the last 1 year
- The stock has generated a return of 6.27% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 75.22%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Mochida Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Mochida Pharmaceutical Co., Ltd.
6.27%
0.03
24.86%
Japan Nikkei 225
75.22%
2.67
28.15%
Quality key factors
Factor
Value
Sales Growth (5y)
1.76%
EBIT Growth (5y)
-6.29%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.80
Tax Ratio
29.40%
Dividend Payout Ratio
49.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.13%
ROE (avg)
5.66%
Valuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
0.95
EV to EBIT
11.83
EV to EBITDA
8.75
EV to Capital Employed
0.94
EV to Sales
0.89
PEG Ratio
2.00
Dividend Yield
NA
ROCE (Latest)
7.94%
ROE (Latest)
4.67%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Movement
10What is working for the Company
PRE-TAX PROFIT(Q)
At JPY 2,848 MM has Grown at 573.29%
NET PROFIT(Q)
At JPY 1,574.27 MM has Grown at 1,867.83%
ROCE(HY)
Highest at 5.83%
NET SALES(Q)
At JPY 29,464 MM has Grown at 20.62%
OPERATING PROFIT(Q)
Highest at JPY 3,410 MM
-15What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 8,119.05
CASH AND EQV(HY)
Lowest at JPY 72,554 MM
DEBT-EQUITY RATIO
(HY)
Highest at -14.77 %
INTEREST(Q)
Highest at JPY 42 MM
Here's what is working for Mochida Pharmaceutical Co., Ltd.
Pre-Tax Profit
At JPY 2,848 MM has Grown at 573.29%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (JPY MM)
Net Profit
At JPY 1,574.27 MM has Grown at 1,867.83%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (JPY MM)
Net Sales
At JPY 29,464 MM has Grown at 20.62%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Operating Profit
Highest at JPY 3,410 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Depreciation
Highest at JPY 789 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for Mochida Pharmaceutical Co., Ltd.
Interest
At JPY 42 MM has Grown at 44.83%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Interest Coverage Ratio
Lowest at 8,119.05
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
Highest at JPY 42 MM
in the last five periods and Increased by 44.83% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Cash and Eqv
Lowest at JPY 72,554 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -14.77 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






